Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

Life Sciences, Immunology, Oncology +15

Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.

Eva Lotzová, C. A. Savary, R B Herberman · The Journal of Immunology · 1987 · 213 citations

Life Sciences, Immunology, Oncology +10

Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes <i>in vitro</i>.

Nicholas Zoumbos, J Y Djeu, Neal S. Young · The Journal of Immunology · 1984 · 178 citations

Life Sciences, Hematology, Immunology +17

Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells

Kazuo Oshimi, Y Oshimi, M Akutsu et al. · Blood · 1986 · 176 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.

Arabella B. Tilden, K Itoh, Charles M. Balch · The Journal of Immunology · 1987 · 118 citations · Full text

Life Sciences, Cell Biology, Immunology +13